Abacavir sulfate is a potent nucleoside reverse transcriptase inhibitor agent commonly prescribed in the management of human immunodeficiency virus (HIV) infection. It exerts its therapeutic effect by competitively inhibiting the activity of the viral reverse transcriptase enzyme, thereby hampering the conversion of HIV RNA to DNA. This interferenc